Authors' Reply to Letter to the Editor- in Response to: Comment on Dheyab AM et al. "Long-Term Efficacy of Oral Valganciclovir in Presumed Cytomegalovirus Unilateral Hypertensive Anterior Uveitis"

被引：0

作者：

Dheyab, Abdulsalam M. ^{[1
]}

Albloushi, Abdulrahman F. ^{[1
]}

Al-Zuabi, Asma ^{[1
,3
]}

Altariqi, Sulaiman M. ^{[1
]}

Tobaigy, Mohannad F. ^{[1
]}

Al Fawaz, Abdullah ^{[1
]}

Abu El-Asrar, Ahmed ^{[1
,2
]}

机构：

[1] King Abdulaziz Univ Hosp, Dept Ophthalmol, Airport Rd,POB 245, Riyadh 11411, Saudi Arabia

[2] King Saud Univ, Coll Med, Dr Nasser Al Rashid Res Chair Ophthalmol, Riyadh, Saudi Arabia

[3] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Ophthalmol, Dammam, Saudi Arabia

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2025年 / 33卷 / 02期

关键词：

Anterior uveitis; cytomegalovirus; glaucoma; intraocular pressure; valganciclovir;

D O I：

10.1080/09273948.2024.2389246

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The clinical diagnosis of presumed cytomegalovirus hypertensive anterior uveitis was based on the following criteria: 1) Recurrent episodes of unilateral hypertensive anterior uveitis characterized by acute elevation of intraocular pressure, a few medium-sized or mutton-fat keratic precipitates and mild anterior chamber reaction. These findings might be associated with corneal endotheliitis and iris atrophy. 2) Posterior synechiae and vitreous involvement are typically absent. 3) Intact corneal sensation.

引用

页码：326 / 327

页数：2

共 46 条

[21] Reply to F. Muntoni et al.: "In response to PR Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
Clemens, Paula R.
Hoffman, Eric P.
JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (06) : 1155 - 1157
[22] Letter to the Editor: In response to PR Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
Muntoni, Francesco
Straub, Volker
Servais, Laurent
Mercuri, Eugenio
JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (06) : 1151 - 1153
[23] Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan Response
Iki, Masayuki
Fujimori, Kenji
Okimoto, Nobukazu
Nakatoh, Shinichi
Tamaki, Junko
Ishii, Shigeyuki
Imano, Hironori
Ogawa, Sumito
OSTEOPOROSIS INTERNATIONAL, 2025, 36 (02) : 363 - 364
[24] Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
Iki, Masayuki
Fujimori, Kenji
Okimoto, Nobukazu
Nakatoh, Shinichi
Tamaki, Junko
Ishii, Shigeyuki
Imano, Hironori
Ogawa, Sumito
OSTEOPOROSIS INTERNATIONAL, 2025, 36 (02) : 367 - 368
[25] Answer to the Letter to the Editor of G. Camino-Willhuber concerning "Long-term outcome of targeted therapy for low back pain in elderly degenerative lumbar scoliosis" by Yamada K, et al. (Eur Spine J. 2021;30(7):2020-2032) REPLY
Yamada, Kiyotaka
Fujimoto, Yoshinori
EUROPEAN SPINE JOURNAL, 2022, 31 (06) : 1592 - 1593
[26] Letter to the Editor regarding "Long-term swallow outcomes and factors affecting swallowing dysfunction and quality of life among oral cancer patients: a prospective observational study" by Thaduri et al. Eur Arch Otorhinolaryngol. 2023 Aug 7. doi: 10.1007/s00405-023-08155-x
Topkan, Erkan
Somay, Efsun
Selek, Ugur
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (11) : 5149 - 5150
[27] Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
Fraser, David A.
Diep, Lien M.
Hovden, Inger Anette
Nilsen, Kristian B.
Sveen, Kari Anne
Seljeflot, Ingebjorg
Hanssen, Kristian F.
DIABETES CARE, 2012, 35 (11) : E80 - E80
[28] Letter to the Editor RE: Russo, Editorial Comment on: Treatment Trends and Long-Term Survival Associated with Cryotherapy and Partial Nephrectomy for Small Renal Masses in the National Cancer Database Using Propensity Score Matching by Kitley et al. (From: Russo P. J Endourol 2019;33:415; DOI: 10.1089/end.2019.0121)
Kitley, Weston
Bahler, Clint D.
JOURNAL OF ENDOUROLOGY, 2019, 33 (05) : 416 - 416
[29] Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's Letter to the Editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2013;63:998-1008
Abdollah, Firas
Briganti, Alberto
EUROPEAN UROLOGY, 2013, 64 (05) : E103 - E104
[30] Reply to Hsiao-Chun Chang and Shiu-Dong Chung's Letter to the Editor re: Britta Grune, F abian Siegel, Frank Waldbillig, et al. Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients. Eur Urol Focus.
Gruene, Britta
von Hardenberg, Jost
EUROPEAN UROLOGY FOCUS, 2022, 8 (06): : 1866 - 1866

← 1 2 3 4 5 →